Status:
COMPLETED
Preterm Infant Gut (PINGU) - a Norwegian Multi Centre Study
Lead Sponsor:
University Hospital of North Norway
Collaborating Sponsors:
University of Tromso
Oslo University Hospital
Conditions:
Mixed Flora; Infection
Eligibility:
All Genders
1-12 years
Brief Summary
Necrotizing enterocolitis (NEC) is a leading cause of morbidity and mortality among infants in the neonatal intensive care unit (NICU). It has been postulated that abnormal colonization of the preterm...
Detailed Description
Necrotizing enterocolitis (NEC) is a leading cause of morbidity and mortality among infants in the neonatal intensive care unit (NICU). Prematurity is the most important risk factor for NEC. The patho...
Eligibility Criteria
Inclusion
- Preterm infants with gestational age 24-27 weeks/birth weight \< 1000 g, treated with probiotics (target number 26)
- Preterm infants with gestational age 29-31 weeks/birth weight 1000-1500 g, not treated with probiotics (target number 26)
- Term infants (target number 10)
Exclusion
- Extremely preterm infants with gestational age below 24 weeks
- Preterm infants (24-31 weeks) with life threatening complications during 1 week of age
- Infants with congenital malformations
Key Trial Info
Start Date :
March 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02197468
Start Date
March 1 2015
End Date
November 1 2015
Last Update
March 11 2019
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Haukeland Universtiy Hospital
Bergen, Norway, 5021
2
Oslo University Hospital, Rikshospitalet
Oslo, Norway, 0424
3
Oslo University Hospital, Ullevaal
Oslo, Norway, 0424
4
Ahus University Hospital
Oslo, Norway